Pure Global AI
NCT06359730Completed

Incidence and Risk Factors of Low Anterior Resection Syndrome

Incidence, Risk Factors Of Low Anterior Resection Syndrome And Validation Of LARS Score Among Egyptian Patients
Zagazig UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Colorectal Cancer
Drug/Device/Intervention
LARS score questionnaire
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Zagazig University
Location
Zagazig, Egypt
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2017
End date
Dec 01, 2022
Enrollment
120 participants
Primary outcome

age,sex,medical disease,site of tumor,neoadjuvant therapy,site of anastmosis,type of meso-rectal excision,adjuvant therapy,type of surgery,type of anastmosis,LARS score

Summary

Sphincter sparing surgery is oftentimes associated with bowel dysfunction complaints, namely
 the low anterior resection syndrome (LARS). The LARS questionnaire is widely used to assess
 this syndrome.
 
 With advances in colorectal surgery, sparing sphincter surgeries are gaining popularity. But
 symptoms after surgery can affect the quality of life which has psychomotor effects. Low
 anterior resection syndrome score is a worldwide known questionnaire. Many countries have
 accredited validation and translation of this questionnaire, but to our knowledge; it is the
 first time in Egypt.

ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06359730
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06359730 through Pure Global AI's free database. This phase not specified trial is sponsored by Zagazig University and is currently Completed. The study focuses on Colorectal Cancer. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.